Review



compound 7n  (MultiTarget Pharmaceuticals)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MultiTarget Pharmaceuticals compound 7n
    Compound 7n, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compound 7n/product/MultiTarget Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    compound 7n - by Bioz Stars, 2026-04
    90/100 stars

    Images



    Similar Products

    compound 7n  (Selleck Chemicals)
    94
    Selleck Chemicals compound 7n
    PIK3CD inhibitors suppressed GC cell viability in vitro. (A) Four GC cell lines as indicated were treated with Acalisib, Compound <t>7n</t> and Idelalisib for 48 h, and then CCK‐8 analysis was performed. IC 50s were determined by GraphPad Prism 7 using the nonlinear regression subprogram. (B) Colony formation assays with GC cells treated with different concentrations of Acalisib, Compound 7n and Idelalisib for 2 weeks. Data are represented as mean ± SD of independent experiments ( n = 3). * p < 0.05, ** p < 0.01. GC, gastric cancer; IC 50s , inhibitory concentrations; SD, standard deviation.
    Compound 7n, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compound 7n/product/Selleck Chemicals
    Average 94 stars, based on 1 article reviews
    compound 7n - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    compound 7n  (MultiTarget Pharmaceuticals)
    90
    MultiTarget Pharmaceuticals compound 7n
    PIK3CD inhibitors suppressed GC cell viability in vitro. (A) Four GC cell lines as indicated were treated with Acalisib, Compound <t>7n</t> and Idelalisib for 48 h, and then CCK‐8 analysis was performed. IC 50s were determined by GraphPad Prism 7 using the nonlinear regression subprogram. (B) Colony formation assays with GC cells treated with different concentrations of Acalisib, Compound 7n and Idelalisib for 2 weeks. Data are represented as mean ± SD of independent experiments ( n = 3). * p < 0.05, ** p < 0.01. GC, gastric cancer; IC 50s , inhibitory concentrations; SD, standard deviation.
    Compound 7n, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compound 7n/product/MultiTarget Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    compound 7n - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    pmma evonik plexiglas® 7n, molding compound  (Evonik)
    90
    Evonik pmma evonik plexiglas® 7n, molding compound
    PIK3CD inhibitors suppressed GC cell viability in vitro. (A) Four GC cell lines as indicated were treated with Acalisib, Compound <t>7n</t> and Idelalisib for 48 h, and then CCK‐8 analysis was performed. IC 50s were determined by GraphPad Prism 7 using the nonlinear regression subprogram. (B) Colony formation assays with GC cells treated with different concentrations of Acalisib, Compound 7n and Idelalisib for 2 weeks. Data are represented as mean ± SD of independent experiments ( n = 3). * p < 0.05, ** p < 0.01. GC, gastric cancer; IC 50s , inhibitory concentrations; SD, standard deviation.
    Pmma Evonik Plexiglas® 7n, Molding Compound, supplied by Evonik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pmma evonik plexiglas® 7n, molding compound/product/Evonik
    Average 90 stars, based on 1 article reviews
    pmma evonik plexiglas® 7n, molding compound - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    compounds 7n 7ao  (Reaction Biology Corporation)
    90
    Reaction Biology Corporation compounds 7n 7ao
    PIK3CD inhibitors suppressed GC cell viability in vitro. (A) Four GC cell lines as indicated were treated with Acalisib, Compound <t>7n</t> and Idelalisib for 48 h, and then CCK‐8 analysis was performed. IC 50s were determined by GraphPad Prism 7 using the nonlinear regression subprogram. (B) Colony formation assays with GC cells treated with different concentrations of Acalisib, Compound 7n and Idelalisib for 2 weeks. Data are represented as mean ± SD of independent experiments ( n = 3). * p < 0.05, ** p < 0.01. GC, gastric cancer; IC 50s , inhibitory concentrations; SD, standard deviation.
    Compounds 7n 7ao, supplied by Reaction Biology Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compounds 7n 7ao/product/Reaction Biology Corporation
    Average 90 stars, based on 1 article reviews
    compounds 7n 7ao - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    PIK3CD inhibitors suppressed GC cell viability in vitro. (A) Four GC cell lines as indicated were treated with Acalisib, Compound 7n and Idelalisib for 48 h, and then CCK‐8 analysis was performed. IC 50s were determined by GraphPad Prism 7 using the nonlinear regression subprogram. (B) Colony formation assays with GC cells treated with different concentrations of Acalisib, Compound 7n and Idelalisib for 2 weeks. Data are represented as mean ± SD of independent experiments ( n = 3). * p < 0.05, ** p < 0.01. GC, gastric cancer; IC 50s , inhibitory concentrations; SD, standard deviation.

    Journal: Journal of Cell Communication and Signaling

    Article Title: JAK3/STAT5 signaling‐triggered upregulation of PIK3CD contributes to gastric carcinoma development

    doi: 10.1002/ccs3.12017

    Figure Lengend Snippet: PIK3CD inhibitors suppressed GC cell viability in vitro. (A) Four GC cell lines as indicated were treated with Acalisib, Compound 7n and Idelalisib for 48 h, and then CCK‐8 analysis was performed. IC 50s were determined by GraphPad Prism 7 using the nonlinear regression subprogram. (B) Colony formation assays with GC cells treated with different concentrations of Acalisib, Compound 7n and Idelalisib for 2 weeks. Data are represented as mean ± SD of independent experiments ( n = 3). * p < 0.05, ** p < 0.01. GC, gastric cancer; IC 50s , inhibitory concentrations; SD, standard deviation.

    Article Snippet: PI3Kδ inhibitors, including Acalisib (#S5818), compound 7n (#S8693) and Idelalisib (#S2226), STAT3/STAT5 inhibitor SH‐4‐54 (#S7337), STAT3 inhibitor BP‐1‐102 (#S7769), and JAK3 inhibitor JANEX‐1 (#S5903) were purchased from Selleck Chemicals.

    Techniques: In Vitro, CCK-8 Assay, Standard Deviation